Le Lézard
Classified in: Health, Business
Subjects: NPT, AVO

AARP Statement on Social Security COLA Announcement


WASHINGTON, Oct. 10, 2019 /PRNewswire/ -- AARP Chief Executive Officer Jo Ann Jenkins released the following statement in response to today's announcement of the 2020 cost-of-living adjustment (COLA) in Social Security benefits:

AARP national logo. (PRNewsfoto/AARP)

"Social Security is the largest source of retirement income for most retirees, so today's announcement of a 1.6 percent COLA increase, while modest, will help Social Security beneficiaries and their families as they try to keep up with rising prices.

"Social Security's annual COLA amount typically does not keep pace with all the increases in living expenses that most seniors face, including the costs of housing, food, transportation and, especially, health care and prescription drugs. AARP's recent Rx Price Watch report found that retail drug prices increased by twice the rate of inflation during 2017, and have exceeded the inflation rate for at least 12 consecutive years.

"AARP will continue our advocacy for bipartisan solutions to help ensure the long-term solvency of the Social Security program, as well as adequate benefits for recipients. We will also continue to fight for lower health care and prescription drug costs, which are eating up a growing share of Social Security benefits."

For information about Social Security benefits and claiming strategies, those approaching retirement age may visit AARP's Social Security Resource Center.

About AARP
AARP is the nation's largest nonprofit, nonpartisan organization dedicated to empowering people 50 and older to choose how they live as they age. With a nationwide presence and nearly 38 million members, AARP strengthens communities and advocates for what matters most to families: health security, financial stability and personal fulfillment. AARP also produces the nation's largest circulation publications: AARP The Magazine and AARP Bulletin. To learn more, visit www.aarp.org or follow @AARP and @AARPadvocates on social media.

SOURCE AARP


These press releases may also interest you

at 19:05
FOR EU TRADE AND MEDICAL MEDIA ONLY. NOT FOR DISTRIBUTION IN BENELUX. The Janssen Pharmaceutical Companies of Johnson & Johnson announced yesterday interim results from the CHRYSALIS study (NCT02609776) evaluating amivantamab, a fully human...

at 17:30
Aimee Daramus, Psy.D., clinical psychologist, has been quoted on topics related to mental illness in Bustle, HuffPost, wellandgood.com, Mic.com, and several other media outlets. On Sept. 15, 2020, Callisto Press released her first book, Understanding...

at 14:01
Eli Lilly and Company today announced Verzenio® (abemaciclib) in combination with standard adjuvant endocrine therapy (ET) significantly decreased the risk of breast cancer recurrence by 25 percent compared to standard adjuvant ET alone for people...

at 12:35
AstraZeneca and Merck , known as MSD outside the United States and Canada, today announced final results from the Phase III PROfound trial that showed LYNPARZA (olaparib) demonstrated a statistically significant and clinically meaningful improvement...

at 12:35
AstraZeneca and Merck , known as MSD outside the United States and Canada, today announced final results from the Phase 3 PROfound trial which showed LYNPARZA demonstrated a statistically significant and clinically meaningful improvement in overall...

at 12:00
In lieu of an in-person update to the media, Dr. Theresa Tam, Canada's Chief Public Health Officer, issued the following statement today: "There have been 142,774 cases of COVID-19 in Canada, including 9,211 deaths. 87% of people have now recovered....



News published on 10 october 2019 at 10:33 and distributed by: